NO20061417L - Syreinneholdende oxaliplatinformuleringer - Google Patents

Syreinneholdende oxaliplatinformuleringer

Info

Publication number
NO20061417L
NO20061417L NO20061417A NO20061417A NO20061417L NO 20061417 L NO20061417 L NO 20061417L NO 20061417 A NO20061417 A NO 20061417A NO 20061417 A NO20061417 A NO 20061417A NO 20061417 L NO20061417 L NO 20061417L
Authority
NO
Norway
Prior art keywords
acid
formulation
containing oxaliplatin
oxaliplatin
oxaliplatin formulations
Prior art date
Application number
NO20061417A
Other languages
English (en)
Norwegian (no)
Inventor
Vanstone Darryl Whittaker
Julie Aikun Liu
Original Assignee
Mayne Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904627A external-priority patent/AU2003904627A0/en
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Publication of NO20061417L publication Critical patent/NO20061417L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20061417A 2003-08-28 2006-03-28 Syreinneholdende oxaliplatinformuleringer NO20061417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003904627A AU2003904627A0 (en) 2003-08-28 Pharmaceutical Formulation
PCT/AU2004/001168 WO2005020980A1 (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations

Publications (1)

Publication Number Publication Date
NO20061417L true NO20061417L (no) 2006-03-28

Family

ID=34230045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061417A NO20061417L (no) 2003-08-28 2006-03-28 Syreinneholdende oxaliplatinformuleringer

Country Status (11)

Country Link
US (5) US20050090544A1 (ja)
EP (2) EP2243480A1 (ja)
JP (4) JP2007504098A (ja)
CN (3) CN102048723A (ja)
CA (1) CA2537170A1 (ja)
DE (1) DE112004001563T5 (ja)
GB (1) GB2421911A (ja)
HK (1) HK1111894A1 (ja)
NO (1) NO20061417L (ja)
NZ (1) NZ545591A (ja)
WO (1) WO2005020980A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
EP2243480A1 (en) * 2003-08-28 2010-10-27 Mayne Pharma Pty Ltd Pharmaceutical formulations comprising oxaliplatin and an acid.
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
US20100267824A1 (en) * 2007-11-12 2010-10-21 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
AU2010296180B2 (en) 2009-09-21 2016-05-05 Bio-Synectics, Inc Oxaliplatin nanoparticles and method for preparing same
JP5929607B2 (ja) * 2012-08-06 2016-06-08 ニプロ株式会社 オキサリプラチン製剤
TWI615390B (zh) * 2013-04-26 2018-02-21 賽諾菲公司 ５－氯－噻吩－２－羧酸［（ｓ）－２－［甲基－３－（２－側氧基－吡咯啶－１－基）－苯磺醯基胺基］－３－（４－甲基－哌嗪－１－基）－３－側氧基－丙基］－醯胺之酒石酸鹽

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US19514A (en) * 1858-03-02 Improvement in seeding-machines
IL114852A (en) * 1994-08-08 2000-02-29 Debiopharm Sa Pharmaceutically stable preparation of oxaliplatinum
JP3862758B2 (ja) * 1996-03-11 2006-12-27 喜徳 喜谷 二核白金錯体、その調製方法及びその錯体を含有する医薬組成物
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
AU768169B2 (en) 1999-08-30 2003-12-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
EP2243480A1 (en) * 2003-08-28 2010-10-27 Mayne Pharma Pty Ltd Pharmaceutical formulations comprising oxaliplatin and an acid.
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions

Also Published As

Publication number Publication date
NZ545591A (en) 2008-11-28
EP2243480A1 (en) 2010-10-27
WO2005020980A1 (en) 2005-03-10
CN101703467A (zh) 2010-05-12
DE112004001563T5 (de) 2006-07-27
JP6078593B2 (ja) 2017-02-08
JP2007504098A (ja) 2007-03-01
JP2008201804A (ja) 2008-09-04
US20050090544A1 (en) 2005-04-28
US20060264501A1 (en) 2006-11-23
CA2537170A1 (en) 2005-03-10
JP2015180699A (ja) 2015-10-15
CN102048723A (zh) 2011-05-11
GB2421911A (en) 2006-07-12
US20100063145A1 (en) 2010-03-11
US20100035982A1 (en) 2010-02-11
JP2014080426A (ja) 2014-05-08
HK1111894A1 (en) 2008-08-22
JP2012072191A (ja) 2012-04-12
EP1680103A4 (en) 2009-03-25
US20070155833A1 (en) 2007-07-05
GB0606187D0 (en) 2006-05-10
EP1680103A1 (en) 2006-07-19
CN101022790A (zh) 2007-08-22

Similar Documents

Publication Publication Date Title
NO20061417L (no) Syreinneholdende oxaliplatinformuleringer
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
NO20050204L (no) Kombinasjoner av legemidler for behandling av neoplasmer
WO2003079979A3 (en) Method for treating congestive heart failure
GEP20063895B (en) Platinum derivative pharmaceutical formulations
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
BRPI0406667A (pt) Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
IS2630B (is) Meðferð á fráhvarfseinkennum
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
IS8186A (is) Meðferð fyrir uppskurð á verkjum eftir uppskurð
MX2023005533A (es) Derivado de triazina diona, metodo de preparacion y aplicacion del mismo en medicina.
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
NO20064755L (no) Kombinasjonsterapi
WO2004071397A3 (en) Combination therapy of zd6474 with 5-fu or/and cpt-11
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
JP2003528919A5 (ja)
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
TW418100B (en) Device for transdermal and phonophoretic combination treatment and its therapeutic uses
BRPI0412408A (pt) métodos para a produção de um efeito de redução antiangiogênico e/ou de permeabilidade vascular e para o tratamento de um cáncer em um animal de sangue quente tal como um ser humano, composição farmacêutica, kit, e uso de azd2171 ou um sal farmaceuticamente aceitável deste e zd1839 ou um sal farmaceuticamente aceitável deste

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application